Two Sigma Advisers’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
1,672,200
+385,000
| +30% | +$474K | ﹤0.01% | 1108 |
|
|
2025
Q1 | $1.42M | Buy |
1,287,200
+129,700
| +11% | +$143K | ﹤0.01% | 1295 |
|
|
2024
Q4 | $1.05M | Buy |
1,157,500
+357,500
| +45% | +$323K | ﹤0.01% | 1438 |
|
|
2024
Q3 | $789K | Sell |
800,000
-23,900
| -3% | -$23.6K | ﹤0.01% | 1515 |
|
|
2024
Q2 | $742K | Sell |
823,900
-336,800
| -29% | -$303K | ﹤0.01% | 1708 |
|
|
2024
Q1 | $1.37M | Buy |
1,160,700
+59,900
| +5% | +$70.7K | ﹤0.01% | 1417 |
|
|
2023
Q4 | $1M | Buy |
1,100,800
+47,400
| +4% | +$43.3K | ﹤0.01% | 1648 |
|
|
2023
Q3 | $877K | Sell |
1,053,400
-649,500
| -38% | -$541K | ﹤0.01% | 1578 |
|
|
2023
Q2 | $2.04M | Sell |
1,702,900
-137,500
| -7% | -$165K | 0.01% | 1191 |
|
|
2023
Q1 | $2.32M | Buy |
1,840,400
+15,700
| +0.9% | +$19.8K | 0.01% | 1198 |
|
|
2022
Q4 | $3.96M | Buy |
1,824,700
+957,000
| +110% | +$2.08M | 0.01% | 875 |
|
|
2022
Q3 | $10.4M | Buy |
867,700
+562,600
| +184% | +$6.74M | 0.03% | 492 |
|
|
2022
Q2 | $2.55M | Buy |
305,100
+7,300
| +2% | +$61.1K | 0.01% | 1087 |
|
|
2022
Q1 | $2.59M | Buy |
297,800
+32,600
| +12% | +$283K | 0.01% | 1107 |
|
|
2021
Q4 | $3M | Buy |
265,200
+61,600
| +30% | +$697K | 0.01% | 995 |
|
|
2021
Q3 | $2.56M | Sell |
203,600
-155,100
| -43% | -$1.95M | 0.01% | 1118 |
|
|
2021
Q2 | $2.91M | Sell |
358,700
-131,500
| -27% | -$1.07M | 0.01% | 1117 |
|
|
2021
Q1 | $4.53M | Buy |
490,200
+289,400
| +144% | +$2.68M | 0.01% | 888 |
|
|
2020
Q4 | $1.94M | Buy |
200,800
+50,100
| +33% | +$485K | 0.01% | 1278 |
|
|
2020
Q3 | $1.87M | Buy |
150,700
+97,000
| +181% | +$1.2M | 0.01% | 1195 |
|
|
2020
Q2 | $698K | Buy |
+53,700
| New | +$698K | ﹤0.01% | 1746 |
|